Improving quality control for CAR T cell therapies
Drug Discovery World
AUGUST 10, 2022
Finally, in 2017, after years of improving T cell engineering techniques, the first chimeric antigen receptor (CAR) T cell therapy received FDA approval. Since 2017, five CAR T cell therapies have been approved and have shown incredible success in the clinic. Measuring the pharmacokinetics of CAR T cells.
Let's personalize your content